Echocardiografhic changes in dogs long term treated with doxorubicin;Alterações ecocardiográficas em cães sob tratamento prolongado com doxorrubicina

Arquivo Brasileiro de Medicina Veterinaria e Zootecnia

Volumn 57, Issue 3, 2005, Pages 300-306

  Silva, C E V ^a,c   Camacho, A A ^b  

^a Mestre em Clínica Médica Veterinária   (Italy)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^c Asa Sul ^*  (Brazil)

Author keywords

Cardiotoxicity; Dog; Doxorubicin; Echocardiography

Indexed keywords

ANIMALIA; CANIS FAMILIARIS;

EID: 31544458927     PISSN: 01020935     EISSN: 01020935     Source Type: Journal    
DOI: 10.1590/s0102-09352005000300004     Document Type: Article

References (22)

1. BERG, J.; WEINSTEIN, M.J.; SPRINGFIELD, D.S. et al. Results of surgery and doxorubicin chemotherapy in dogs with osteosarcoma. J. Am. Vet. Med. Assoc., v.206, p.1555-1560, 1995.
2. BOON, J.A. Acquired heart disease. In: _. Manual of veterinary echocardiography. Baltimore: Williams & Wilkins, 1998. cap.4, p.320-328.
3. BROWNLIE, S.E.; COBB, M.A. Observations on the development of congestive heart failure in irish wolfhounds with dilated cardiomyopathy. J. Small Anim. Pract., v.40, p.371-377, 1999.
4. CALVERT, C.A.; BROWN, J. Use of M-mode echocardiography in the diagnosis of congestive cardiomyopathy in doberman pinschers. J. Am. Vet. Med. Assoc., v.189, p.293-297, 1986.
5. CALVERT, C.A.; CHAPMAN, W.L.; TOAL, R.L. Congestive cardiomyopathy in doberman pinscher dogs. J. Am. Vet. Med. Assoc., v.181, p.598-602, 1982.
6. CRYSTAL, M.A.; RUSH, J.E. ECG of the month. J. Am. Vet. Med. Assoc., v.199, p.48-50, 1991.
7. DEFRANCESCO, T.C.; HAUCK, M.L. What's new in doxorubicin-induced cardiotoxicity. In: AMERICAN COLLEGE OF VETERINARY INTERNAL MEDICINE FORUM, 18., 2000, Seattle,Washington. Proceedings... p.121-122.
8. GANZ, W.I.; SRIDHAR, K.S; GANZ, S.S. et al. Review of tests for monitoring doxorubicin-induced cardiomyopathy. Oncology, v.53, p.461-470, 1996.
9. HAMLIN, R.L. Pathophysiology of the failing heart. In: FOX, P.R.; SISSON. D.; MOÏSE, N.S. Textbook of canine and feline cardiology. 2.ed. Philadelphia: W.B. Saunders, 1999. cap.11, p.205-215.
10. HANAI, K.; TAKABA, K.; MANABE, S. et al. Evaluation of cardiac function by echocardiography in dogs treated with doxorubicin. J. Toxicol. Sci., v.21, p.1-10, 1996.
11. JACOBS, G.J. Cardiomypathies: their classification and pathophysiologic features. Vet. Med., v.91, p.436-444, 1996a.
12. JACOBS, G.J. Secondary canine cardiomyopathies: their causes and characteristics. Vet. Med., v.91, p.534-542, 1996b.
13. KHANNA, C.; LUND, E.M.; REDIC, K.A. et al. Randomized controlled trial of doxorubicin versus dactinomycin in a multiagent protocol for treatment of dogs with malignant lymphoma. J. Am. Vet. Med. Assoc., v.213, p.986-990, 1998.
14. KITTLESON, M.D. Pathophysiology of heart failure. In: KITTLESON, M.D.; KIENLE, R.D. Small animal cardiovascular medicine. Saint Louis: Mosby, 1998. cap.9, p.136-148.
15. LEFRAK, E.A.; PIǏHA, J.; ROSENHEIM, S. et al. A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer, v.32, p.302-314, 1973.
16. MAULDIN, G.E.; FOX, P.R.; PATNAIK, A.K. et al. Doxorubicin-induced cardiotoxicosis: clinical features in 32 dogs. J. Vet. Int. Med., v.6, p.82-88, 1992.
17. SCHWARTZ, R.G.; McKENZIE, W.B.; ALEXANDER, J. et al. Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy. Am. J. Med., v.82, p. 1109-1118, 1987.
18. SISSON, D.; O'GRADY, M.R.; CALVERT, C.A. Myocardial diseases of dogs. In: FOX, P.R.; SISSON. D.; MOÏSE, N.S. Textbook of canine and feline cardiology. 2.ed. Philadelphia: W.B. Saunders, 1999. cap.27, p.581-619.
19. SUSANECK, S.J. Doxorubicin therapy in the dog. J. Am. Vet. Med. Assoc., v.182, p.70-72, 1983.
20. TOYODA, Y.; MASYOSHI, O.; MOHAMMED, A.K. A canine model of dilated cardiomyopathy induced by repetitive intracoronary doxorubicin administration. J. Thorac. Cardiovasc. Surg., v.115, p.1.367-1.373, 1998.
21. VAN VLEET, J.F.; FERRANS, V.J.; WEIRICH, W.E. Cardiac disease induced by chronic adriamycin administration in dogs and an evaluation of vitamin E and selenium as cardioprotectans. Am. J. Pathol., v.99, p. 13-42, 1980.
22. VOLLMAR, A.C. Use of echocardiography in the diagnosis of dilated cardiomyopathy in irish wolfhounds. J. Am. Anim. Hasp. Assoc., v.35, 279-283, 1999.